Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

New ALK tyrosine kinase receptor inhibitors identified at Blueprint Medicines

Nov. 2, 2017

Rice University discovers novel viridicatumtoxin B analogues

Nov. 2, 2017

AbbVie identifies new lysophosphatidic acid receptor 1 antagonists

Oct. 31, 2017

Baylor College of Medicine describes novel Steroid receptor coactivator regulators

Oct. 31, 2017

New dopamine D1 receptor positive allosteric modulators divulged by UCB

Oct. 31, 2017

The University of Michigan discloses new proteolysis targeting chimera compounds

Oct. 31, 2017

Novel leukotriene A-4 hydrolase inhibitors identified at Novartis

Oct. 31, 2017

New antibacterials patented by Actelion Pharmaceuticals

Oct. 30, 2017

Novel proto-oncogene c-Ret inhibitors identified at Cancer Research Technology

Oct. 30, 2017

Boehringer Ingelheim discovers new orexin receptor type 1 antagonists

Oct. 30, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...